Journals / Anatolian Current Medical Journal / 2026 / Volume: 8 Issue: 4

Crescent subtype distribution and tubulointerstitial injury as predictors of renal function and renal replacement therapy in patients with crescent formation on renal biopsy: a single-centre retrospective cohort study

Gamze Ergün(Bartin State Hospital)0000-0003-1605-7231
Arzu Özdemir(UNIVERSITY OF HEALTH SCIENCES, İSTANBUL BAKIRKÖY DR. SADİ KONUK TRAINING RESEARCH CENTER)0000-0001-7651-7282
Mürvet Yılmaz(UNIVERSITY OF HEALTH SCIENCES, İSTANBUL BAKIRKÖY DR. SADİ KONUK TRAINING RESEARCH CENTER)0000-0003-0270-9227
Pages
—
Publication Date
2026-07-16
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Fibrous crescents were associated with the need for RRT in this exploratory analysis and warrant evaluation in larger prospective cohorts.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aims: Crescent formation on renal biopsy, encompassing the histopathological spectrum of crescentic glomerulonephritis (CrGN), represents one of the most aggressive patterns of glomerular injury and is characterised by rapid decline in kidney function.
📊
Key Findings & Data:Results: A total of 78 patients with complete histopathological and clinical data were included.
💡
Conclusion & Impact:Fibrous crescents were associated with the need for RRT in this exploratory analysis and warrant evaluation in larger prospective cohorts.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Crescent formation · renal biopsy · interstitial fibrosis

Abstract

Aims: Crescent formation on renal biopsy, encompassing the histopathological spectrum of crescentic glomerulonephritis (CrGN), represents one of the most aggressive patterns of glomerular injury and is characterised by rapid decline in kidney function. The prognostic significance of different crescent subtypes and tubulointerstitial lesions remains incompletely understood. This study aimed to evaluate the association between crescent subtype distribution, tubulointerstitial pathology, and renal function parameters (eGFR, serum creatinine) and clinical outcomes (renal replacement therapy [RRT], mortality) in patients with crescent formation on renal biopsy. Methods: This retrospective observational study included patients with crescent formation on renal biopsy who underwent kidney biopsy at Bakırköy Dr. Sadi Konuk Training and Research Hospital. Clinical, laboratory, and histopathological data were obtained from hospital records. Crescent subtypes (cellular, fibrocellular, and fibrous), interstitial fibrosis, and tubular atrophy were recorded. Associations between histopathological findings and renal function parameters (eGFR and serum creatinine) and clinical outcomes (RRT and mortality) were analysed. Results: A total of 78 patients with complete histopathological and clinical data were included. Fibrocellular crescents demonstrated the strongest association with renal dysfunction, showing a significant negative correlation with eGFR and a positive correlation with serum creatinine. Fibrous crescents were significantly associated with lower eGFR and higher creatinine levels. Interstitial fibrosis and tubular atrophy were also associated with worse renal function at presentation. During follow-up, RRT was required in 12 patients (15.4%) and 5 patients (6.4%) died. Fibrous crescent percentage was significantly higher in patients requiring RRT. Conclusion: Crescent subtype distribution and tubulointerstitial injury are important determinants of renal function in patients with crescent formation on renal biopsy. In multivariable analysis, cellular crescent percentage and tubular atrophy were independently associated with lower eGFR, while cellular and fibrocellular crescents were independently associated with higher serum creatinine. Fibrous crescents were associated with the need for RRT in this exploratory analysis and warrant evaluation in larger prospective cohorts.

🔖

Cite This Article

Ergün, G., Özdemir, A., Yılmaz, M. (2026). Crescent subtype distribution and tubulointerstitial injury as predictors of renal function and renal replacement therapy in patients with crescent formation on renal biopsy: a single-centre retrospective cohort study. Anatolian Current Medical Journal, Volume: 8 Issue: 4. https://doi.org/10.38053/acmj.1925736

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Stella M, Locatelli L, Sala FM, et al. The value of the current histological scores and classifications of ANCA glomerulonephritis in predicting long-term outcome. Clin Kidney J. 2024;17(7):sfae125. doi:10.1093/ckj/sfae125
  2. Anguiano L, Kain R, Anders HJ. The glomerular crescent: triggers, evolution, resolution, and implications for therapy. Curr Opin Nephrol Hypertens. 2020;29(3):302-309. doi:10.1097/MNH.0000000000000596
  3. Zhang P, Yang X, Gao CL, Wu W, Xia ZK. Crescentic glomerulonephritis in children: short-term follow-up predicts long-term outcome. Front Pediatr. 2023;11:1206168. doi:10.3389/fped.2023.1206168
  4. Rao R, Singh PP, Kumar O, Krishna A, Patel PS. The clinicopathological correlation and outcome of glomerulonephritis with crescent: a single-center study. Cureus. 2024;16(2):e54996. doi:10.7759/cureus.54996
  5. Berden AE, Ferrario F, Hagen EC, et al. Histopathologic classification of ANCA-associated glomerulonephritis. J Am Soc Nephrol. 2010;21(10): 1628-1636. doi:10.1681/ASN.2010050477
  6. Ergun G, Ozdemir A. The association between hematological indices and prognosis in crescentic glomerulonephritis. Rev Nefrol Dial Traspl. 2026;46(1):03-11.
  7. Jennette JC, Nachman PH. ANCA glomerulonephritis and vasculitis. Clin J Am Soc Nephrol. 2017;12(10):1680-1691. doi:10.2215/CJN.02500317
  8. Yu F, Haas M, Glassock R, Zhao MH. Redefining lupus nephritis: clinical implications of pathophysiologic subtypes. Nat Rev Nephrol. 2017;13(8):483-495. doi:10.1038/nrneph.2017.85
  9. Wen S, Chen S, Lin Y, Li G, Zhang P, Wang W. Clinicopathological characteristics and predictors of renal outcomes in diffuse crescentic glomerulonephritis: a retrospective single-center study from Western China. BMC Nephrol. 2025;26(1):24. doi:10.1186/s12882-024-03923-1
  10. Brix SR, Noriega M, Tennstedt P, et al. Development and validation of a renal risk score in ANCA-associated glomerulonephritis. Kidney Int. 2018;94(6):1177-1188. doi:10.1016/j.kint.2018.07.020
  11. Farris AB, Colvin RB. Renal interstitial fibrosis: mechanisms and evaluation. Curr Opin Nephrol Hypertens. 2012;21(3):289-300. doi:10.1097/MNH.0b013e3283521cfa
  12. Nath KA. Tubulointerstitial changes as a major determinant in the progression of renal damage. Am J Kidney Dis. 1992;20(1):1-17. doi:10.1016/s0272-6386(12)80312-x
  13. Bülow RD, Boor P. Extracellular matrix in kidney fibrosis: more than just a scaffold. J Histochem Cytochem. 2019;67(9):643-661. doi:10.1369/0022155419849388
  14. Guo C, Ye M, Li S, Zhu TT, Rao XR. Anti-glomerular basement membrane disease with IgA nephropathy: a case report. World J Clin Cases. 2022;10(12):3916-3922. doi:10.12998/wjcc.v10.i12.3916